©The Author(s) 2018.
World J Gastroenterol. May 14, 2018; 24(18): 2036-2046
Published online May 14, 2018. doi: 10.3748/wjg.v24.i18.2036
Published online May 14, 2018. doi: 10.3748/wjg.v24.i18.2036
Table 1 Demographics, Tanner stage, disease location, and medications
| Item | n (%) |
| Race | |
| Asian | 12 (14.6) |
| East Asian | 6 |
| South Asian | 6 |
| Black/African American | 1 (1.2) |
| Other | 4 (4.9) |
| White | 65 (79.3) |
| Ethnicity | |
| Hispanic or Latino | 7 (8.5) |
| Not Hispanic or Latino | 75 (91.5) |
| Tanner stage | |
| 1 | 8 (9.8) |
| 2 | 15 (18.3) |
| 3 | 16 (19.5) |
| 4 | 24 (29.3) |
| 5 | 19 (23.2) |
| Disease location | |
| Esophagus or stomach | 9 (11) |
| Small bowel, no colon | 12 (14.6) |
| Colon, no small bowel | 17 (20.7) |
| Small bowel and colon | 53 (64.6) |
| Perianal disease | 49 (59.8) |
| Medication | |
| Adalimumab | 4 (4.9) |
| 5-Aminosalicylates | 50 (61.0) |
| Antibiotics | 14 (17.1) |
| Azathioprine/6-Mercaptopurine | 44 (53.7) |
| Infliximab | 20 (24.4) |
| Methotrexate | 7 (8.5) |
| Steroids ever | 55 (67.1) |
- Citation: Gupta N, Lustig RH, Chao C, Vittinghoff E, Andrews H, Leu CS. Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn’s disease. World J Gastroenterol 2018; 24(18): 2036-2046
- URL: https://www.wjgnet.com/1007-9327/full/v24/i18/2036.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i18.2036